Effective treatment of ductal carcinoma in situ with a HER-2-targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer
Takahiro Yoshida(Osaka International Cancer Institute), Saraswati Sukumar(Johns Hopkins University)
Cited by 37
Related Papers
RNA editing in the Wilms' tumor susceptibility gene, WT1.
|Genes & Development|1994|187
High‐dose chemotherapeutics of intravesical chemotherapy rapidly induce mitochondrial dysfunction in bladder cancer‐derived spheroids
|Cancer Science|2014|42
HEYL Regulates Neoangiogenesis Through Overexpression in Both Breast Tumor Epithelium and Endothelium
|Frontiers in Oncology|2021|20
Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
|Clinical Epigenetics|2021|17